| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,086,000 | 2,491,000 | 3,387,000 | 3,351,000 | | Cost of Revenue | 1,280,000 | 1,394,000 | 1,744,000 | 1,602,000 | | | Gross Profit | 806,000 | 1,097,000 | 1,643,000 | 1,749,000 | | | Operating Expenses | | Research Development | 386,000 | 431,000 | 507,000 | 488,000 | | Selling General and Administrative | 305,000 | 362,000 | 389,000 | 428,000 | | Non Recurring | 105,000 | 254,000 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,000 | 50,000 | 747,000 | 833,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,000 | (14,000) | 9,000 | 16,000 | | Earnings Before Interest And Taxes | 15,000 | 36,000 | 756,000 | 849,000 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 15,000 | 36,000 | 756,000 | 849,000 | | Income Tax Expense | (2,000) | (71,000) | 194,000 | 260,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 17,000 | 107,000 | 562,000 | 589,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 17,000 | 107,000 | 562,000 | 589,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $17,000 | $107,000 | $562,000 | $589,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
